|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 37/00 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 1940465 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06826560.2 |
| Date of filing the European patent application | 2006-10-24 | |
| (97) | Date of publication of the European application | 2008-07-09 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-01 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (86) | Number | PCT/US2006/041479 |
| Date | 2006-10-24 |
| (87) | Number | WO 2007/050607 |
| Date | 2007-05-03 |
| (30) | Number | Date | Country code |
| 730435 P | 2005-10-26 | US | |
| 742125 P | 2005-12-02 | US |
| (72) |
LOWE, Phil, CH
GRAM, Hermann, DE
JUNG, Thomas, AT
WRIGHT, Timothy, US
MUNDEL, Trevor, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naujas anti-IL-1 beta antikūnų panaudojimas |
| NOVEL USE OF ANTI IL-1BETA ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-09-23 | 19 | 347.00 EUR |
| 2025-10-24 |